SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BBII
BBII 0.0550+37.5%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ahanson1131 who wrote (19)2/9/2000 11:54:00 AM
From: Dako  Read Replies (2) of 28
 
What Kernen knows is that a vast number of "investors" will leap at and wildly overpay for stocks based on a key buzz word or two without any real thought about what was actually reported or what price the stock has flown to.

An FDA clearance to sell a test kit to detect HIV is nothing new in the marketplace and simply becomes the 31st different blood test kit that Boston Biomedica sells. The first 30 didn't do a lot for its $5 stock price, and after investors realize that this is not a cure for AIDS, as many apparently do, this "new" little test product will be no different,

Anyone caught up in this bit of nonsense will be best served by an immediate exit and re-entry when the dust settles sometime next week.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News